EGFR and cholangiocarcinoma: Moreover, PGE2-mediated activation of the EP3 isoform 4 receptor also enhances the progression of CC cells through the upregulation of β-catenin via the Src/EGFR/PI3K/AKT/GSK-3β pathway [84].